(NASDAQ:STAA) NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (together, âBroadwoodâ) currently intend to vote against the proposed acquisition of STAAR Surgical Company by Alcon Inc. Broadwood is STAARâs largest shareholder, owning 27.3% of STAARâs common shares outstanding. Broadwood has owned STAAR shares for over 30 years, has been the companyâs largest shareholder since 2007, and has long been one of STAARâs largest and most supportive stockholders, including by providing capital
Related Questions
How will Broadwood's opposition affect the likelihood of the AlconâSTAAR merger closing and the expected deal premium?
What are the potential valuation and governance implications for STAAR if the deal is blocked or renegotiated?
How might Broadwood's stance impact market sentiment and shortâterm volatility for both STAAR (STAA) and Alcon (ALC)?